These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 15387893

  • 1. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J, Schätzlein AG.
    Expert Rev Mol Med; 2004 Sep 13; 6(19):1-17. PubMed ID: 15387893
    [Abstract] [Full Text] [Related]

  • 2. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
    Brumlik MJ, Daniel BJ, Waehler R, Curiel DT, Giles FJ, Curiel TJ.
    Expert Opin Drug Deliv; 2008 Jan 13; 5(1):87-103. PubMed ID: 18095930
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ligand-based targeted therapy for cancer tissue.
    Das M, Mohanty C, Sahoo SK.
    Expert Opin Drug Deliv; 2009 Mar 13; 6(3):285-304. PubMed ID: 19327045
    [Abstract] [Full Text] [Related]

  • 6. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
    Hamad I, Moghimi SM.
    Expert Opin Drug Deliv; 2008 Feb 13; 5(2):205-19. PubMed ID: 18248319
    [Abstract] [Full Text] [Related]

  • 7. The polyamine transport system as a target for anticancer drug development.
    Palmer AJ, Wallace HM.
    Amino Acids; 2010 Feb 13; 38(2):415-22. PubMed ID: 19956998
    [Abstract] [Full Text] [Related]

  • 8. Integrin targeted drug and gene delivery.
    Wang Z, Chui WK, Ho PC.
    Expert Opin Drug Deliv; 2010 Feb 13; 7(2):159-71. PubMed ID: 20095940
    [Abstract] [Full Text] [Related]

  • 9. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec 13; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H, Bharate GY, Daruwalla J.
    Eur J Pharm Biopharm; 2009 Mar 13; 71(3):409-19. PubMed ID: 19070661
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
    Shenoy VS, Vijay IK, Murthy RS.
    J Pharm Pharmacol; 2005 Apr 13; 57(4):411-22. PubMed ID: 15831200
    [Abstract] [Full Text] [Related]

  • 17. A new probe for targeting drug delivery system.
    Yu Z, Wang B, Sui J, Feng Y, Zheng C.
    Med Hypotheses; 2009 Jan 13; 72(1):43-4. PubMed ID: 18829175
    [Abstract] [Full Text] [Related]

  • 18. Essential properties of drug-targeting delivery systems.
    Petrak K.
    Drug Discov Today; 2005 Dec 13; 10(23-24):1667-73. PubMed ID: 16376827
    [Abstract] [Full Text] [Related]

  • 19. Drug penetration in solid tumours.
    Minchinton AI, Tannock IF.
    Nat Rev Cancer; 2006 Aug 13; 6(8):583-92. PubMed ID: 16862189
    [Abstract] [Full Text] [Related]

  • 20. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
    Marcucci F, Lefoulon F.
    Drug Discov Today; 2004 Mar 01; 9(5):219-28. PubMed ID: 14980540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.